×
About 4,338 results
FDA clears new indications for existing Lyme disease tests that may help streamline diagnoses
https://www.fda.gov/news-events/press-announcements/fda-clears-new-indications-existing-lyme-disease-tests-may-help-streamline-diagnoses

Jul 28th, 2019 - Today, the U.S. Food and Drug Administration cleared for marketing four previously cleared tests with new indications to aid in the diagnosis of Lyme disease. The tests cleared today are the first time that a test has been indicated to follow a new testing paradigm in which two tests called enzyme immunoassays (EIA) are run concurrently or sequentially, rather than the current two-step process ...

Dosing | HUMIRA (adalimumab)
https://www.humiraconnect.com/psoriatic-arthritis/dosing

Jun 26th, 2019 - Dosing See Important Safety Information, including BOXED WARNING.

Filgotinib
https://www.glpg.com/filgotinib

Mar 6th, 2019 - Filgotinib is a highly selective JAK1 inhibitor, discovered and developed by Galapagos using its target and drug discovery technology platform. In more than 1,600 patient years of rheumatoid arthritis (RA) and Crohn's disease clinical study experience, filgotinib has shown a rapid onset of action, potentially best-in-class efficacy and favorable findings on safety and tolerability. From a regul...

Upadacitinib Meets All Primary and Ranked Secondary Endpoints Including Superiority Versus Adalimumab in Phase 3 Study in Rheumatoid Arthritis
https://news.abbvie.com/news/upadacitinib-meets-all-primary-and-ranked-secondary-endpoints-including-superiority-versus-adalimumab-in-phase-3-study-in-rheumatoid-arthritis.htm

Apr 8th, 2018 - AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced positive top-line results from the Phase 3 SELECT-COMPARE clinical trial showing that after 12 weeks, upadacitinib (15 mg, once-daily) met the primary endpoints of ACR20a and clinical remissionb versus placebo.1 All ranked secondary endpoints were also achieved versus either placebo or adalimumab (40 mg eve...

ACTEMRA® (tocilizumab) intravenous drip infusion or injection
https://www.actemrahcp.com/

Find valuable ACTEMRA® (tocilizumab) information, including an ACTEMRA® dosing calculator, RA patient brochure, ACTEMRA® prescription guide and the ISI. IMPORTANT SAFETY INFORMATION-RA: ACTEMRA is a prescription medicine called an interleukin-6 (IL-6) receptor antagonist.

Advil For Professionals
http://advilaide.com/

Advil safety and efficacy clinical information

ASTERO® (lidocaine)
http://genscopharma.com/products/astero/

Astero® is the only FDA-approved prescription hydrogel and 4% Lidocaine HCl for pain associated with wound healing and vasculitis. Available by prescription only, Astero® provides superior wound healing and has a rapid onset of action in 3-5 minutes.

BINOSTO® (alendronate sodium)
https://www.binosto.com/content/healthcare-professionals

You know the risks are real. Osteoporosis can change a woman's world. With BINOSTO ® you can strengthen her world with the proven power of alendronate in a buffered effervescent solution. Now, you can give your patients:

DEPO-MEDROL® (methylprednisolone acetate)
https://www.pfizer.com/products/product-detail/depo_medrol

Depo-Medrol® (methylprednisolone acetate injectable suspension, USP) Multidose Vials. Prescribing Information. Depo-Medrol® (methylprednisolone acetate injectable suspension, USP) Single-Dose ...

INFLECTRA (infliximab-dyyb) LYOPHILIZED CONCENTRATE FOR INJECTION, FOR INTRAVENOUS USE
http://www1.pfizerpro.com/product/inflectra/hcp

Patients treated with infliximab products are at increased risk for developing serious infections that may lead to hospitalization or death. Most patients who developed these infections were taking concomitant immunosuppressants such as methotrexate or corticosteroids.

HUMIRA (adalimumab) INJECTION
https://www.humirapro.com/

Official health care professional site from AbbVie Inc. Find safety and prescribing information, including BOXED WARNING, for HUMIRA (adalimumab).

KENALOG (triamcinolone acetonide) INJECTION
https://www.henryschein.com/kenalog.aspx

Kenalog, or triamcinolone acetonide, is a corticosteroid hormone (glucocorticoid) that is used to treat a wide variety of medical conditions.

LYMEPAK (doxycycline hyclate tablets) Prescribing Information
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209844s000lbl.pdf

LYMEPAK is a tetracycline class drug indicated for the treatment of early Lyme disease (as evidenced by erythema migrans) due to Borrelia burgdorferi in adults and pediatric patients 8 years of age and older weighing 45 kg and above

LYRICA (pregabalin) CAPSULES
https://www1.pfizerpro.com/product/lyrica

See risks and benefits of LYRICA® (pregabalin). Find clinical information about LYRICA Capsules CV, an Rx for FM, pDPN, PHN, & spinal chord injury nerve pain.

KEVZARA® (sarilumab) injection
https://www.kevzarahcp.com/

KEVZARA® (sarilumab) is for adults with moderately to severely active rheumatoid arthritis who had an inadequate response or intolerance to one or more DMARDs.

RENFLEXIS (infliximab-abda) for injection, for intravenous use
https://www.merckconnect.com/renflexis/overview.html

RENFLEXIS is indicated for reducing signs and symptoms of active arthritis, inhibiting the progression of structural damage, and improving physical function in ...

COLCHICINE CAPSULES
http://www.west-ward.com/en/Products/ProductsRoot/Colchicine%20Capsules

Colchicine capsules are indicated for prophylaxis of gout flares in adults.

COLCIGEL® (colchicinum 4X transdermal gel)
http://genscopharma.com/products/colcigel/

ColciGel® is a prescription transdermal gel that provides relief of acute gout flares utilizing patented Isopeutic® Transdermal Technology

COLCRYS TABLETS (colchicine, USP)
https://www.colcryshcp.com/

COLCRYS (colchicine, USP) is a prescription medicine used in adults to prevent and treat gout flares. Product details including taking COLCRYS, savings card if eligible and resources for patients. See full safety and Prescribing Information.